Results 91 to 100 of about 5,540,950 (140)
Thyroid Eye Disease Simplified
Delhi Journal of Ophthalmology, 2019 Sachin M. SALVI
doaj +1 more source
Assessment of tear-evaporation rate in thyroid-gland patients
Clinical Ophthalmology, 2019 Ali Abusharaha,1 Abdulaziz A Alturki,1 Saud A Alanazi,1 Raied Fagehi,1 Naji Al-Johani,2 Gamal A El-Hiti,1 Ali M Masmali1 1Department of Optometry, College of Applied Medical Sciences, King Saud University, Riyadh 11433, Saudi Arabia; 2Department of ...
Abusharaha A +6 more
doaj
Immunology of Thyroid Eye Disease: New Treatments on the Horizon?
, 2010 GD is an autoimmune disease where circulating antibodies \cause hyperthyroidism and lead to ...
Raymond S. Douglas
core
Beyond a typical thyroid eye disease
Middle East African Journal of Ophthalmology, 2013 openaire +3 more sources
Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit
Orbit, 2017 \ua9 2017 Taylor & Francis This article provides baseline data and highlight any major deficiencies in the current level of care provided for adult patients with thyroid eye disease (TED). We used prospective nonrandomized cross-sectional multicenter
Petros Perros, Bijay Vaidya
exaly +5 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
BMJ, 2009
Thyroid eye disease is a relatively rare condition, with an incidence of 2.9 to 16.0 cases per 100 000 population per year.1 The disease mainly affects women. Many patients experience distressing symptoms, and a few develop sight threatening complications. Patients are often young or middle aged and at the peak of their career.
Petros, Perros +2 more
openaire +4 more sources
Thyroid eye disease is a relatively rare condition, with an incidence of 2.9 to 16.0 cases per 100 000 population per year.1 The disease mainly affects women. Many patients experience distressing symptoms, and a few develop sight threatening complications. Patients are often young or middle aged and at the peak of their career.
Petros, Perros +2 more
openaire +4 more sources
Seminars in Ophthalmology, 1999
Thyroid eye disease is the most common cause of unilateral and bilateral proptosis in adults. It occurs most frequently in women aged 30 to 50 years. Clinical features include eyelid retraction, periorbital edema, conjunctival injection and chemosis, proptosis, extraocular muscle restriction, exposure keratopathy, and optic nerve compromise.
I U, Scott, M R, Siatkowski
openaire +2 more sources
Thyroid eye disease is the most common cause of unilateral and bilateral proptosis in adults. It occurs most frequently in women aged 30 to 50 years. Clinical features include eyelid retraction, periorbital edema, conjunctival injection and chemosis, proptosis, extraocular muscle restriction, exposure keratopathy, and optic nerve compromise.
I U, Scott, M R, Siatkowski
openaire +2 more sources
Neurologic Clinics, 2010
Thyroid eye disease (TED) is the most common cause of proptosis in adults, and should always be a consideration in patients with unexplained diplopia, pain, or optic nerve dysfunction. At least 80% of TED is associated with Graves disease (GD), and at least 50% of patients with GD develop clinically evident symptomatic TED.
Kimberly P, Cockerham, Stephanie S, Chan
openaire +2 more sources
Thyroid eye disease (TED) is the most common cause of proptosis in adults, and should always be a consideration in patients with unexplained diplopia, pain, or optic nerve dysfunction. At least 80% of TED is associated with Graves disease (GD), and at least 50% of patients with GD develop clinically evident symptomatic TED.
Kimberly P, Cockerham, Stephanie S, Chan
openaire +2 more sources
Treatment of Thyroid Eye Disease
Current Treatment Options in Neurology, 2010Thyroid eye disease (TED) is an autoimmune disease characterized by varying degrees of proptosis, congestion and inflammation of the extraocular tissues, and eyelid retraction. It is usually seen in the setting of Graves' disease, but the severity of TED does not necessarily correlate with the level of systemic disease in a given patient.
Margaret E, Phillips +2 more
openaire +2 more sources